We are live on
!
Find out more
TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
140 hedge funds and large institutions have $671M invested in Taro Pharmaceutical Industries Ltd. in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 47 increasing their positions, 53 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
1% more funds holding
Funds holding: 139 → 140 (+1)
6% less capital invested
Capital invested by funds: $712M → $671M (-$41.6M)
11% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 53
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
85% less call options, than puts
Call options by funds: $213K | Put options by funds: $1.38M
Holders
140
Holders Change
+1
Holders Change %
+0.72%
% of All Funds
3.49%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
13
Increased
47
Reduced
53
Closed
12
Calls
$213K
Puts
$1.38M
Net Calls
-$1.17M
Net Calls Change
+$339K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.6M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.75M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.26M |
| 4 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
+$1.85M |
| 5 |
AG
Aperio Group
Sausalito,
California
|
+$1.83M |
